Salivary Antioxidants and Oxidative Stress in Psoriatic Patients: Can Salivary Total Oxidant Status and Oxidative Status Index Be a Plaque Psoriasis Biomarker?

Table 3

Salivary gland function in psoriasis patients and control subjects.

Patient characteristics	Control		Psoriasis
		Median (min–max)		Median (min–max)
	NWS flow rate (mL/min)		0.28 (0.10–0.89)		0.24 (0.10–0.63)
SWS flow rate (mL/min)		0.99 (0.23–3.5)		0.76 (0.2–2.4)
Total protein in NWS (μg/mL)		1190.00 (180.60–2127.00)		857.60 (309.50–1280.00)
Total protein in SWS (μg/mL)		917.10 (478.00–2002.00)		439.20 (227.90–965.40)
Amylase in NWS (μmol/mg protein)		0.23 (0.03–0.39)		0.10 (0.01–0.20)
Amylase in SWS (μmol/mg protein)		0.30 (0.03–0.59)		0.16 (0.01–0.40)

Abbreviations: : number of patients; NWS: nonstimulated whole saliva; SWS: stimulated whole saliva. vs. the control group.